rs370908799

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_001103.4(ACTN2):c.1892G>A(p.Arg631His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R631C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)

Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

ACTN2
NM_001103.4 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 9.88

Publications

0 publications found

Variant links:

Genes affected

ACTN2 (HGNC:164): (actinin alpha 2) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a muscle-specific, alpha actinin isoform that is expressed in both skeletal and cardiac muscles. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]

ACTN2 Gene-Disease associations (from GenCC):

intrinsic cardiomyopathy
Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Laboratory for Molecular Medicine, ClinGen
myopathy, congenital, with structured cores and z-line abnormalities
Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
dilated cardiomyopathy 1AA
Inheritance: AD Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
familial isolated dilated cardiomyopathy
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
heart conduction disease
Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
myopathy, distal, 6, adult-onset, autosomal dominant
Inheritance: AD, Unknown Classification: LIMITED Submitted by: Broad Center for Mendelian Genomics, Labcorp Genetics (formerly Invitae)

ACTN2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6

Variant 1-236753999-G-A is Benign according to our data. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038. Variant chr1-236753999-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532038.

BS2

High AC in GnomAdExome4 at 36 AD,Unknown gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
ACTN2	NM_001103.4 link	c.1892G>A	p.Arg631His	missense_variant	Exon 16 of 21	ENST00000366578.6	NP_001094.1	P35609-1
ACTN2	NM_001278343.2 link	c.1892G>A	p.Arg631His	missense_variant	Exon 16 of 21		NP_001265272.1	P35609-2
ACTN2	NR_184402.1 link	n.2264G>A		non_coding_transcript_exon_variant	Exon 18 of 23

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
ACTN2	ENST00000366578.6 link	c.1892G>A	p.Arg631His	missense_variant	Exon 16 of 21	1	NM_001103.4	ENSP00000355537.4		P35609-1

Frequencies

GnomAD3 genomes

AF:

0.0000263

AC:

AN:

152216

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.000414

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000294

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000398

AC:

AN:

251314

AF XY:

0.0000515

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.0000289

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.0000544

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00000880

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000246

AC:

AN:

1461836

Hom.:

Cov.:

AF XY:

0.0000385

AC XY:

AN XY:

727220

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33480

American (AMR)

AF:

0.0000224

AC:

AN:

44724

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26136

East Asian (EAS)

AF:

0.0000252

AC:

AN:

39700

South Asian (SAS)

AF:

0.000255

AC:

AN:

86258

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53366

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.0000108

AC:

AN:

1112010

Other (OTH)

AF:

0.00

AC:

AN:

60394

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.492

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000263

AC:

AN:

152216

Hom.:

Cov.:

AF XY:

0.0000538

AC XY:

AN XY:

74374

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41464

American (AMR)

AF:

0.00

AC:

AN:

15280

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5184

South Asian (SAS)

AF:

0.000414

AC:

AN:

4832

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10628

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.0000294

AC:

AN:

68034

Other (OTH)

AF:

0.00

AC:

AN:

2094

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.563

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.0000283

Hom.:

Bravo

AF:

0.0000151

ESP6500AA

AF:

0.00

AC:

ESP6500EA

AF:

0.000116

AC:

ExAC

AF:

0.0000659

AC:

EpiCase

AF:

0.00

EpiControl

AF:

0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:1Benign:2

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

Cardiovascular phenotype

Uncertain:1

Mar 11, 2025

Ambry Genetics

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The p.R631H variant (also known as c.1892G>A), located in coding exon 16 of the ACTN2 gene, results from a G to A substitution at nucleotide position 1892. The arginine at codon 631 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -

Cardiomyopathy

Benign:1

Feb 13, 2018

CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA

Benign:1

Jun 17, 2023

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.16

BayesDel_addAF

Benign

-0.0068

BayesDel_noAF

Uncertain

0.050

CADD

Pathogenic

(source)

DANN

Uncertain

1.0

DEOGEN2

Uncertain

0.69

.;.;D

Eigen

Pathogenic

0.69

Eigen_PC

Pathogenic

0.73

FATHMM_MKL

Pathogenic

0.97

LIST_S2

Uncertain

0.96

D;D;D

M_CAP

Uncertain

0.088

MetaRNN

Uncertain

0.67

D;D;D

MetaSVM

Uncertain

0.073

MutationAssessor

Uncertain

2.6

.;M;M

PhyloP100

9.9

PrimateAI

Uncertain

0.71

PROVEAN

Uncertain

-3.6

.;D;D

REVEL

Uncertain

0.57

Sift

Benign

0.075

.;T;T

Sift4G

Uncertain

0.0040

D;T;T

Polyphen

0.70

.;.;P

Vest4

0.78

MVP

0.80

MPC

0.65

ClinPred

0.68

GERP RS

5.4

Varity_R

0.41

gMVP

0.67

Mutation Taster

=34/66

disease causing

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.010

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over